Atrial Fibrillation

Patients with HF who received an implantable cardioverter defibrillator that detected severe sleep apnea may be two- to threefold more likely to experience an atrial fibrillation episode, according to a new analysis of DASAP-HF data.

In patients younger than 75 years with atrial fibrillation and concomitant CV conditions, an early rhythm control strategy was associated with better CV outcomes compared with a rate control strategy, researchers reported.

A standardized referral protocol involving the electrophysiology service improved use of optimal therapy in patients with atrial fibrillation presenting to the ED compared with routine care, researchers reported at Heart Rhythm 2022.

Patients who underwent left atrial appendage closure with a next-generation device were significantly less likely to experience in-hospital major adverse events, including pericardial effusion, compared with an earlier-generation device.

Label-concordant dosing may benefit patients on dialysis with nonvalvular atrial fibrillation more than below-label dosing, according to data published in the American Journal of Kidney Diseases.

An app-based mind and body intervention significantly reduced atrial fibrillation-related symptom burden during the 3 months after catheter ablation compared with usual care, according to findings from a randomized controlled trial.

In patients with recently diagnosed atrial fibrillation and a high comorbidity burden, early rhythm control therapy markedly reduced CV death, stroke or hospitalization for HF or ACS, according to new data from the EAST-AFNET 4 trial.

An analysis of single-center data showed same-day discharge after atrial fibrillation ablation increased from 2020 to 2021, with reduction in total time spent in-hospital and no change in readmission rates for adverse events.

WASHINGTON — In patients with atrial fibrillation requiring stroke prevention, the novel factor XIa inhibitor asundexian was associated with lower bleeding rates compared with apixaban, according to the results of the PACIFIC-AF trial.

Association between objectively measured sedentary behavior and incident atrial fibrillation.